(Q39514663)

12 September 2017

title

Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations (English)

1 reference

12 September 2017

4

1 reference

12 September 2017

Terese Magnusson

1

1 reference

12 September 2017

Rudolf Haase

series ordinal

2

1 reference

12 September 2017

Martin Schleef

series ordinal

3

1 reference

12 September 2017

Manfred Ogris

series ordinal

5

1 reference

12 September 2017

language of work or name

1 reference

1 July 2011

1 reference

12 September 2017

published in

Journal of Gene Medicine

1 reference

12 September 2017

volume

13

1 reference

12 September 2017

issue

7-8

1 reference

12 September 2017

page(s)

382-391

1 reference

Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle

12 September 2017

cites work

1 reference

Nonviral gene transfer to skeletal, smooth, and cardiac muscle in living animals

21 January 2018

1 reference

Direct gene transfer into mouse muscle in vivo

21 January 2018

1 reference

Gene expression following direct injection of DNA into liver

21 January 2018

1 reference

CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice

21 January 2018

1 reference

Modulation of plasmid DNA methylation and expression in zebrafish embryos

21 January 2018

1 reference

Time course of gene expression after plasmid DNA gene transfer to the liver

21 January 2018

1 reference

Effects of inflammatory response on in vivo transgene expression by plasmid DNA in mice

21 January 2018

1 reference

Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression.

21 January 2018

1 reference

Long-term transgene expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinucleotides

21 January 2018

1 reference

Reducing the immunostimulatory activity of CpG-containing plasmid DNA vectors for non-viral gene therapy

21 January 2018

1 reference

Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation

21 January 2018

1 reference

Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery

21 January 2018

1 reference

Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer

21 January 2018

1 reference

New recombination methods for Sinorhizobium meliloti genetics

21 January 2018

1 reference

Production of Non Viral DNA Vectors

21 January 2018

1 reference

Toxicity and adaptive immune response to intracellular transgenes delivered by helper-dependent vs. first generation adenoviral vectors

21 January 2018

1 reference

EMBOSS: the European Molecular Biology Open Software Suite

21 January 2018

1 reference

Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN.

21 January 2018

1 reference

PROMO: detection of known transcription regulatory elements using species-tailored searches

21 January 2018

1 reference

Zinc-finger nucleases: the next generation emerges

21 January 2018

1 reference

The expanding universe of transposon technologies for gene and cell engineering.

21 January 2018

1 reference

Episomal vectors for gene therapy

21 January 2018

1 reference

pEPito: a significantly improved non-viral episomal expression vector for mammalian cells

21 January 2018

1 reference

A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells

21 January 2018

1 reference

Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA.

21 January 2018

1 reference

Hydroporation as the mechanism of hydrodynamic delivery

21 January 2018

1 reference

CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression.

21 January 2018

1 reference

Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87.

21 January 2018

1 reference

Transgene expression is associated with copy number and cytomegalovirus promoter methylation in transgenic pigs

21 January 2018

1 reference

Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice

21 January 2018

1 reference

Muscle Damage After Delivery of Naked Plasmid DNA into Skeletal Muscles Is Batch Dependent

21 January 2018

1 reference

Animal-free production of ccc-supercoiled plasmids for research and clinical applications

21 January 2018

1 reference

In vitro and in vivo comparative study of chimeric liver-specific promoters

21 January 2018

1 reference

Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency

21 January 2018

1 reference

Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo

21 January 2018

1 reference

Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome

21 January 2018

1 reference

Reactivation of silenced transgene expression in mouse liver by rapid, large-volume injection of isotonic solution.

21 January 2018

1 reference

Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

21 January 2018

1 reference

CpG content affects gene silencing in mice: evidence from novel transgenes

21 January 2018

1 reference

Strong muscle-specific regulatory cassettes based on multiple copies of the human slow troponin I gene upstream enhancer

21 January 2018

1 reference

High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter

21 January 2018

1 reference

Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector.

21 January 2018

1 reference

Review--the use of immunosuppressive agents to prevent neutralizing antibodies against a transgene product

21 January 2018

1 reference

Challenges and strategies: the immune responses in gene therapy

21 January 2018

1 reference

Controlling the kinetics of transgene expression by plasmid design

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JGM.1585

1 reference

release_52pxjherfrdm7gui4n4445bmye

12 September 2017

Fatcat ID

0 references

1 reference